Global Cloud-based enterprise software and software-driven clinical data solutions provider eClinical Solutions has received a minority investment from global growth equity firm Summit Partners.

Financial terms of the investment were not disclosed.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The latest investment enables the data software solutions provider to support and expand the growth of its Cloud-based Clinical Data Hub platform elluminate. It also supports elluminate-associated data services.

eClinical Solutions co-founder and CEO Raj Indupuri said: “We are delighted to partner with Summit as we enter a new phase of growth.

“Summit has a long history of helping to accelerate growth and scale businesses. We believe their deep experience in the life sciences and HCIT markets will help propel eClinical Solutions to the next level.”

The elluminate platform is the proprietary Clinical Data Hub of eClinical Solutions. It allows life sciences organisations to seamlessly integrate and merge all clinical data sources.

Summit Partners managing director Mark deLaar said: “Biopharmaceutical companies collect millions of data points throughout a clinical trial, ingesting and normalising data from a variety of vendors is a complicated, time-consuming process, one that often extends the time-to-market for a new drug.

“We believe the elluminate platform addresses this challenge head-on, offering a more holistic view of data across the clinical trial process.”

elluminate, which comprises hundreds of clinical trials on its platform, is designed to allow organisations to maximise their clinical data value and regain control of the clinical research process.

It also empowers the organisations to take decisions on clinical trials in a proactive manner.

eClinical Solutions co-founder and president Bob Arnesen said: “The elluminate platform is designed to provide one source of truth for all clinical data along with intuitive data mapping and comprehensive analytics across data sources.

“Summit immediately understood our market and our vision. They have already been instrumental in accelerating our journey.”